Skip to main content
IDWeek 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

Jay A. Fishman, MD (he/him/his)

Professor of Medicine, Director Transplant Infectious Disease
Massachusetts General Hospital - Harvard Medical School
Boston, MA, United States

Jay A. Fishman, M.D. is Professor of Medicine at Harvard Medical School, Director of the Transplant Infectious Diseases and Compromised Host Program at the Massachusetts General Hospital (MGH), and Associate Director of the MGH Transplant Center. Dr. Fishman completed medical school at Johns Hopkins University School of Medicine, internal medicine training and Infectious Disease Fellowship at MGH, and Fellowships in Molecular Biology and Genetics at MGH and Harvard Medical School. Dr. Fishman is a Fellow of the American College of Physicians, the American Society of Transplantation, and the Infectious Disease Society of America. Dr. Fishman established the Transplant and Immunocompromised Host Program of the Massachusetts General Hospital which has trained many of the leaders in this field worldwide. With his clinical experience in the infectious diseases of solid organ and stem cell transplant recipients, oncology patients, and other immunocompromised hosts, his background in immunology, virology and molecular biology provides a unique translational approach to these patients. His laboratory investigates infections in xenotransplantation and viral pathogenesis in transplantation. He has been engaged in clinical trials in transplantation and in molecular studies of opportunistic pathogens (Pneumocystis and viruses) for >30 years. He has a special interest in molecular diagnostics and biotechnology and in medical education. Dr. Fishman directed and published multicenter mechanistic studies under prior CTOT awards for quantitative nucleic acid testing for cytomegalovirus in transplant recipients and for discordant serologic assays for pneumococcus. He has over 300 peer-reviewed publications and is a frequent contributor at international symposia. He is Past-President of the American Society of Transplantation. He has received career achievement awards from the American Society of Transplantation and the Transplantation Society.

Disclosure(s): No financial relationships to disclose

Presentation(s):